SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
30-May-24 6:21 PM View: | Inhibrx, Inc. (INBX) | 30-May-24 | Disposition | 2,055,550 | $30.00 | $61,666,600.00 | (100%) 2.06M to 0 | |
30-May-24 6:09 PM View: | Inhibrx Biosciences, Inc. (INBX) | 29-May-24 | Grant | 513,888 | -- | -- | 100% 0 to 513.89K | |
30-May-24 6:21 PM View: | Inhibrx, Inc. (INBX) | 28-May-24 | Market Sale | 300,000 | $34.30 | $10,290,000.00 | (13%) 2.36M to 2.06M | (11%) |
02-Mar-23 4:17 PM View: | Inhibrx, Inc. (INBX) | 01-Mar-23 | Sale (Planned) | 40,000 | $24.21 | $968,231.00 | (2%) 2.4M to 2.36M | |
02-Feb-23 7:26 PM View: | Inhibrx, Inc. (INBX) | 02-Feb-23 | Sale (Planned) | 11,250 | $25.45 | $286,355.00 | (< 1%) 2.41M to 2.4M | |
02-Feb-23 7:26 PM View: | Inhibrx, Inc. (INBX) | 01-Feb-23 | Sale (Planned) | 28,750 | $24.73 | $710,856.00 | (1%) 2.44M to 2.41M | |
04-Jan-23 5:53 PM View: | Inhibrx, Inc. (INBX) | 04-Jan-23 | Sale (Planned) | 7,105 | $23.48 | $166,829.00 | (< 1%) 2.44M to 2.44M | |
04-Jan-23 5:53 PM View: | Inhibrx, Inc. (INBX) | 03-Jan-23 | Sale (Planned) | 32,895 | $23.77 | $781,770.00 | (1%) 2.48M to 2.44M | |
07-Dec-22 4:30 PM View: | Inhibrx, Inc. (INBX) | 06-Dec-22 | Sale (Planned) | 40,000 | $27.22 | $1,088,680.00 | (2%) 2.52M to 2.48M | |
02-Nov-22 5:04 PM View: | Inhibrx, Inc. (INBX) | 01-Nov-22 | Market Sale (Planned) | 40,000 | $33.51 | $1,340,390.00 | (2%) 2.56M to 2.52M | (14%) |
05-Oct-22 4:15 PM View: | Inhibrx, Inc. (INBX) | 04-Oct-22 | Sale (Planned) | 40,000 | $27.82 | $1,112,810.00 | (2%) 2.6M to 2.56M | |
14-Sep-22 4:09 PM View: | Inhibrx, Inc. (INBX) | 13-Sep-22 | Gift | 160,000 | -- | -- | 6% 2.6M to 2.76M | |
14-Sep-22 4:09 PM View: | Inhibrx, Inc. (INBX) | 13-Sep-22 | Gift | 160,000 | -- | -- | (6%) 2.76M to 2.6M | |
07-Sep-22 4:57 PM View: | Inhibrx, Inc. (INBX) | 06-Sep-22 | Sale (Planned) | 40,000 | $14.91 | $596,274.00 | (2%) 2.64M to 2.6M | |
04-Aug-22 4:33 PM View: | Inhibrx, Inc. (INBX) | 03-Aug-22 | Sale (Planned) | 15,500 | $18.47 | $286,209.00 | (< 1%) 2.65M to 2.64M | |
04-Aug-22 4:33 PM View: | Inhibrx, Inc. (INBX) | 02-Aug-22 | Sale (Planned) | 24,500 | $17.70 | $433,626.00 | (< 1%) 2.68M to 2.65M | |
08-Jul-22 4:03 PM View: | Inhibrx, Inc. (INBX) | 07-Jul-22 | Sale (Planned) | 40,000 | $17.17 | $686,800.00 | (1%) 2.72M to 2.68M | |
07-Apr-22 4:11 PM View: | Inhibrx, Inc. (INBX) | 05-Apr-22 | Sale (Planned) | 400 | $25.04 | $10,016.00 | (< 1%) 2.72M to 2.72M | |
24-Mar-21 7:12 PM View: | Inhibrx, Inc. (INBX) | 24-Mar-21 | Market Sale (Planned) | 17,000 | $19.02 | $323,340.00 | (< 1%) 2.73M to 2.72M | 5% |
18-Feb-21 5:08 PM View: | Inhibrx, Inc. (INBX) | 16-Feb-21 | Market Sale (Planned) | 17,000 | $25.90 | $440,300.00 | (< 1%) 2.75M to 2.73M | 30% |
19-Jan-21 4:16 PM View: | Inhibrx, Inc. (INBX) | 04-Dec-20 | Gift | 160,000 | -- | -- | 6% 2.67M to 2.83M | |
19-Jan-21 4:16 PM View: | Inhibrx, Inc. (INBX) | 04-Dec-20 | Gift | 160,000 | -- | -- | (6%) 2.83M to 2.67M |